
Caredx Inc is a diagnostics & research business based in the US. Caredx shares (CDNA) are listed on the NASDAQ and all prices are listed in US Dollars. Caredx employs 633 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Caredx
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDNA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Caredx stock price (NASDAQ: CDNA)
Use our graph to track the performance of CDNA stocks over time.Caredx shares at a glance
Latest market close | $21.48 |
---|---|
52-week range | $19.35 - $92.17 |
50-day moving average | $25.56 |
200-day moving average | $41.24 |
Wall St. target price | $59.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.95 |
Buy Caredx shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Caredx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Caredx price performance over time
Historical closes compared with the close of $21.48 from 2022-06-30
1 week (2022-06-24) | -9.29% |
---|---|
1 month (2022-06-02) | -18.82% |
3 months (2022-03-29) | -46.45% |
6 months (2021-12-31) | -52.77% |
1 year (2021-07-02) | -76.13% |
---|---|
2 years (2020-07-02) | -38.04% |
3 years (2019-07-02) | 35.71 |
5 years (2017-06-30) | 1,835.14% |
Caredx financials
Revenue TTM | $308.4 million |
---|---|
Gross profit TTM | $199 million |
Return on assets TTM | -5.4% |
Return on equity TTM | -10.68% |
Profit margin | -16.09% |
Book value | $8.62 |
Market capitalisation | $1.1 billion |
TTM: trailing 12 months
Caredx share dividends
We're not expecting Caredx to pay a dividend over the next 12 months.
Caredx share price volatility
Over the last 12 months, Caredx's shares have ranged in value from as little as $19.345 up to $92.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Caredx's is 0.8126. This would suggest that Caredx's shares are less volatile than average (for this exchange).
Caredx overview
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc.
Caredx in the news
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in APYX Medical Corporation (APYX), CareDx, Inc. (CDNA), and Verrica Pharmaceuticals, Inc. (VRCA) and Encourages Investors to Contact the Firm
DEADLINE ALERT for CDNA, SPRO, LMPX, IONQ: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP, and Dentsply Sirona and Encourages Investors to Contact the Firm
Frequently asked questions
What percentage of Caredx is owned by insiders or institutions?Currently 1.941% of Caredx shares are held by insiders and 104.11% by institutions. How many people work for Caredx?
Latest data suggests 633 work at Caredx. When does the fiscal year end for Caredx?
Caredx's fiscal year ends in December. Where is Caredx based?
Caredx's address is: 1 Tower Place, South San Francisco, CA, United States, 94080 What is Caredx's ISIN number?
Caredx's international securities identification number is: US14167L1035 What is Caredx's CUSIP number?
Caredx's Committee on Uniform Securities Identification Procedures number is: 14167L103
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert